![Stephanie Bewick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stephanie Bewick served as the Chief Business Officer at Destiny Pharma Plc from 2021 to 2023.
Prior to that, she worked as the Vice President of Business Development at Summit Therapeutics, Inc. Dr. Bewick received an undergraduate degree from The University of Edinburgh and a doctorate from the University of Bristol.
Ehemalige bekannte Positionen von Stephanie Bewick
| Unternehmen | Position | Ende |
|---|---|---|
| DESY PHAR | Corporate Officer/Principal | 01.03.2023 |
| SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | - |
Ausbildung von Stephanie Bewick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Destiny Pharma Plc
 Destiny Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops novel antimicrobial products | Health Technology |
Summit Therapeutics, Inc.
 Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
